Busch Matthew C.'s Form 4 filing
Amgen Inc (AMGN) · filed May 6, 2025
- Accession no.
- 0001127602-25-013526
- Filed
- May 6, 2025
- Trade date
- May 2, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $279.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Busch Matthew C.CIK 0001987926 | Officer (VP, Finance & CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2025 | Common Stock | FTax withholdingDisposed | −28 | $283.78 | −$7,945.84 | 5,071 | Direct | |
| May 2, 2025 | Common Stock | FTax withholdingDisposed | −37 | $283.78 | −$10,499.86 | 5,034 | Direct | |
| May 2, 2025 | Common Stock | SSaleDisposed | −1,000 | $279.69 | −$279,690 | 4,034 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.